Skip to main navigation Skip to search Skip to main content

Clinical Impact of Additional Cytogenetic Aberrations, cKIT and RAS Mutations, and Treatment Elements in Pediatric t(8;21)-AML: Results From an International Retrospective Study by the International Berlin-Frankfurt-Munster Study Group

  • K. Klein
  • , G. Kaspers
  • , C.J. Harrison
  • , HB Beverloo
  • , A. Reedijk
  • , M. Bongers
  • , J. Cloos
  • , A. Pession
  • , D. Reinhardt
  • , M. Zimmerman
  • , U. Creutzig
  • , M Dworzak
  • , T. Alonzo
  • , D. Johnston
  • , B. Hirsch
  • , M. Zapotocky
  • , B. De Moerloose
  • , A. Fynn
  • , V. Lee
  • , T. Taga
  • A. Tawa, A. Auvrignon, B. Zeller, E. Forestier, C. Salgado, W. Balwierz, A. Popa, J. Rubnitz, S. Raimondi, B Gibson

Research output: Contribution to journalArticleAcademicpeer-review

18 Downloads (Pure)
Original languageUndefined/Unknown
Pages (from-to)4247-4258
JournalJournal of clinical oncology
Volume33
Issue number36
DOIs
Publication statusPublished - 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this